Benefit of Percutaneous Coronary Intervention in Early Latecomers With Acute ST-Segment Elevation Myocardial Infarction
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- AMERICAN JOURNAL OF CARDIOLOGY110(9) · pp.1275 · 2012
- 피인용
- Web of Science 15
- JCR IF
- JCR 2011 3.368
- ISSN
- 0002-9149
저자
- Sim, Doo Sun제1저자전남대학교, KO
- Jeong, Myung-Ho교신저자전남대학교, KO
- Ahn, Youngkeun전남대학교, KO
- Kim, Young Jo영남대학교, KO
- Chae, Shung Chull경북대학교, KO
- 홍택종부산대학교, 의과대학, 의학과, 내과학교실, KO
- Seong, In Whan충남대학교, KO
- Chae, Jei Keon전북대학교, KO
- Kim, Chong Jin경희대학교, KO
- Cho, Myeong Chan충북대학교, KO
- Rha, Seung-Woon고려대학교, Guro Hosp, KO
- Bae, Jang Ho건양대학교, KO
- Seung, Ki Bae가톨릭대학교, St Marys Hosp, KO
- Park, Seung Jung아산병원, KO
초록
The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction (STEMI). We evaluated the efficacy of PCI in 2,344 stable patients with STEW. presenting 12 to 72 hours after symptom onset. Patients who had impaired hemodynamics or who had undergone fibrinolysis or immediate or urgent PCI were excluded. The patients were divided into the PCI group (n = 1,889) and medical treatment group (n = 455). The 12-month clinical outcome was compared between the 2 groups. After adjustment using propensity score stratification, the PCI group had lower mortality (3.1% vs 10.1%; hazard ratio 0.31; 95% confidence interval 0.20 to 0.47; p < 0.001) and a lower incidence of composite death/myocardial infarction (3.8% vs 11.2%; hazard ratio 0.36; 95% confidence interval 0.25 to 0.53; p < 0.001) at 12 months. The benefit of PCI was consistent across all subgroups, including patients presenting without chest pain. In conclusion, in stable patients with STEM! presenting 12 to 72 hours after symptom onset, PCI was associated with significant improvement in the 12-month clinical outcome. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:1275-1281)
키워드
COLLATERAL BLOOD-FLOWPRIMARY ANGIOPLASTYMECHANICAL REPERFUSIONPROPENSITY SCOREARTERYBIASASSOCIATIONOCCLUSIONSURVIVALTHERAPY
식별자
- WoS UID
- 000311003400012



로그인
연구물 목록으로